Prof. Dr. Sabahattin KAYMAKOĞLU

Yayın Ağı

Makaleler 157

1. Extra intestinal manifestations may increase the risk of synchronous and metachronous development of other extraintestinal manifestations in patients with Crohn’s disease

Ozkahraman A., Kayar Y., Dertli R., Konur S., Kılıc G., Baran B., et al.

Scientific Reports , cilt.15, sa.1, 2025 (SCI-Expanded)

2. A prospective study on the role of non-invasive tests in the evaluation of diabetes mellitus associated steatotic liver disease

İstemihan Z., Bektaş F., Bardak A. E., Kızıltaş C., Kemeç G., İmanov Z., et al.

Scientific Reports , cilt.15, sa.1, 2025 (SCI-Expanded)

3. Letter on “Long-Term Dynamic Changes of Alanine Aminotransferase Levels Are Associated With Liver-Related Events in Nucleos(t)ide Analogue-Treated Chronic Hepatitis B Patients in China”

Bilgin E., Çavuş B., Kaymakoğlu S.

Alimentary Pharmacology and Therapeutics , cilt.62, sa.9, ss.959-960, 2025 (SCI-Expanded)

4. Real World Efficacy and Safety of Switching From Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide in Liver Transplant Recipients

Bektas E., Yilmaz A., Kikili C. I., Nuriyev K., Istemihan Z., Senkal I. V., et al.

Transplant Infectious Disease , cilt.27, sa.5, 2025 (SCI-Expanded) Sürdürülebilir Kalkınma

5. The role of GALAD score in the surveillance of hepatocellular carcinoma.

İstemihan Z., Şenkal İ. V., Karaca D., Nurıyev K., Rustamzade A., Genç Uluçeçen S., et al.

Scientific reports , cilt.15, sa.1, ss.22279, 2025 (SCI-Expanded)

6. The Role of Pancreatic Enzyme Insufficiency in the Etiology of Functional Dyspepsia Resistant to Standard Treatment

kemik f., CEYLAN G., Aydın A. F., Çavuş B., Ormeci A., Imanov Z., et al.

Turkish Journal of Gastroenterology , cilt.36, sa.7, ss.467-473, 2025 (SCI-Expanded)

7. Results in chronic hepatitis B patients using tenofovir and entecavir for at least 10 years; HBV clearance rare, disease outcomes good: An observational cohort study

Istemihan Z., Kemeç G., Cebeci T., Çetin O., Uluçeçen S. G., Rüstemzade A., et al.

Medicine (United States) , cilt.104, sa.23, 2025 (SCI-Expanded)

8. Large Scale MRI Collection and Segmentation of Cirrhotic Liver

Jha D., Susladkar O. K., Gorade V., Keles E., Antalek M., Seyithanoglu D., et al.

SCIENTIFIC DATA , sa.1, 2025 (SCI-Expanded)

9. The Role of MicroRNA-192-5p in the Pathogenesis of Crohn's Disease

Dicle E. O., Ulucecen S. G., İSTEMİHAN Z., ÇAVUŞ B., OĞUZ F., KAYMAKOĞLU S., et al.

HLA , cilt.105, 2025 (SCI-Expanded)

10. Inflammation and Immune-Based Scores Predict Prognosis for Patients with Hepatocellular Carcinoma: A Pilot Single-Center Study

Dirim M. G., Ormeci A. C., Cavus B., Poyanli A., Serin K. R., Akyuz F., et al.

Turkish Journal of Gastroenterology , cilt.36, sa.4, ss.219-228, 2025 (SCI-Expanded)

11. Hepatopulmoner Sendrom

İstemihan Z., Kaymakoğlu S.

Türkiye Klinikleri Gastroenterohepatoloji Dergisi , cilt.18, ss.47-52, 2025 (Hakemli Dergi)

12. What are the predictors of malignancy in inflammatory bowel disease?

İstemihan Z., Çavuş B., Bardak A. E., Kirkoğlu A. M., Kiziltaş C., Silay R., et al.

Turkish Journal of Medical Sciences , cilt.55, sa.4, ss.846-854, 2025 (SCI-Expanded)

13. Virological and Biochemical Effects of Tenofovir Alafenamide in Different Patient Groups With Chronic Hepatitis B Virus Infection in Real-World Cohort

Bektas E., Yilmaz A., Kikili C. I., Nuriyev K., Istemihan Z., Senkal I. V., et al.

International Journal of Hepatology , cilt.2025, sa.1, 2025 (ESCI)

14. Aceruloplasminemia as a rare hereditary disease: four case reports in a single center

İstemihan Z., İmanov Z., Çavuş B., Çifcibaşı Örmeci A., Akyüz F., Beşışık S. F., et al.

Baylor University Medical Center Proceedings , sa.0, ss.1-4, 2024 (Scopus)

15. The Consequences of HLA Screening in the Prevention of Graft-Versus-Host Disease in Living Donor Liver Transplantation

Ercan L. D., DURMAZ Ö., KAYMAKOĞLU S., ÖNAL Z., Buyukbabani N., GÜLLÜOĞLU M., et al.

PEDIATRIC TRANSPLANTATION , cilt.28, sa.6, 2024 (SCI-Expanded)

16. Functional Bowel Disorder Management in Routine Practice with Tips for Hot Topics: Expert Opinion Review

Akyuz F., ÇELEBİ A., Doǧan I., ERZİN Y. Z., KAV T., SOYTÜRK M., et al.

Turkish Journal of Gastroenterology , cilt.35, sa.6, ss.423-439, 2024 (SCI-Expanded)

17. Two Cases of Malignant Transformation in Crohn’s Disease with Perianal Involvement

DAĞCI G., VARELCİ S., BÜYÜK M., ÇAVUŞ B., ÇİFCİBAŞI ÖRMECİ A., AKYÜZ F., et al.

Kare Publishing , cilt.2, 2023 (Hakemli Dergi)

18. Is the Y90-radioembolization treatment effective on the intermediate-advanced stage of hepatocellular carcinoma and what is the albumin-bilirubin score’s prediction factor for survival?

Evirgen S., ÇAVUŞ B., Gokturk S., Iliaz R., ÖZKAN Z. G., Baran B., et al.

Hepatology Forum , cilt.4, sa.3, ss.103-107, 2023 (Scopus)

19. Efficacy and Safety of Sofosbuvir and Ledipasvir for Hepatitis C in Kidney Transplant Recipients: A Single-center Retrospective Observational Study

Artan A. S., Mirioğlu Ş., İstemihan Z., Aksoy E., Dirim A. B., Çavuş B., et al.

BALKAN MEDICAL JOURNAL , cilt.40, sa.3, ss.182-187, 2023 (SCI-Expanded) Sürdürülebilir Kalkınma

20. Mucocutaneous Manifestations and Associated Factors in Patients with Crohn's Disease

Kayar Y., Dertli R., Konür Ş., Ağın M., Al Kafee A., Baran B., et al.

The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology , cilt.33, sa.11, ss.945-954, 2022 (SCI-Expanded)

21. Different Faces of Eosinophilic Infiltration of Gastrointestinal System

İSTEMİHAN Z., ÇAVUŞ B., BERKER N., Nuriyev K., Şenkal V., İmanov Z., et al.

Journal of Enterocolitis , cilt.1, sa.3, ss.68-71, 2022 (Hakemli Dergi)

22. SINGLE CENTER EXPERIENCE OF WILSON DISEASE

Demir K., Ormeci A. C., Cavus B., Akyuz F., Besisik F., Kaymakoglu S.

HEPATOLOGY , cilt.76, 2022 (SCI-Expanded)

23. Cell-free methylation of RASSF1 and CDKN2AIP genes in the diagnosis of hepatocellular carcinoma associated with hepatitis B virus cirrhosis

Telli P., Ozturk N. B., Hakan M. T., Cavus B., Ormeci A. C., Yakut A., et al.

HEPATOLOGY FORUM , cilt.3, sa.3, ss.77-81, 2022 (ESCI) Sürdürülebilir Kalkınma

24. What is the effect of subepithelial lesions of the esophagus on esophageal motility?

Oermeci A., Cavus B., Akas R., Istemihan Z., Imanov Z., Senkal V., et al.

European review for medical and pharmacological sciences , cilt.26, sa.17, ss.6300-6309, 2022 (SCI-Expanded) Sürdürülebilir Kalkınma

25. Eliminating Viral Hepatitis in Turkey: Achievements and Challenges

AKARCA U. S., BAYKAM N., GÜNER H. R., GÜNŞAR F., İDİLMAN R., Kaymakoglu S., et al.

VIRAL HEPATIT DERGISI-VIRAL HEPATITIS JOURNAL , sa.2, ss.47-54, 2022 (ESCI)

26. Is anterior segment OCT superior to slit-lamp biomicroscopic examination for Kayser Flesicher ring in Wilson's disease?

Ormeci A., Bayraktar S., Isik A. O., Cavus B., Akas R., Istemihan Z., et al.

European review for medical and pharmacological sciences , cilt.26, sa.14, ss.5178-5185, 2022 (SCI-Expanded)

27. Cyclosporine Therapy as a Rescue Treatment in Steroid Refractory Acute Severe Ulcerative Colitis: A Real Life Data From a Tertiary Center

Evirgen S., Iliaz R., Akyuz F., Cavus B., Gokturk S., Ormeci A., et al.

TURKISH JOURNAL OF GASTROENTEROLOGY , cilt.33, sa.6, ss.463-469, 2022 (SCI-Expanded)

28. A Case of Budd-Chiari Syndrome Associated With Antiphospholipid Syndrome Treated Successfully by Transjugular Intrahepatic Portosystemic Shunt

Torun E. S., Erciyestepe M., Yalcinkaya Y., Gul A., Inanc M., Ocal L., et al.

CLINICAL MEDICINE INSIGHTS-CASE REPORTS , cilt.15, 2022 (ESCI)

29. Are Hepatobiliary Manifestations Related to the Site of Involvement in Inflammatory Bowel Disease?

İstemihan Z., Çifcibaşı Örmeci A., Çavuş B., Şenkal İ. V., İmanov Z., Nuriyev K., et al.

Journal of Enterocolitis , cilt.1, ss.12-16, 2022 (Hakemli Dergi)

30. Is Having Inflammatory Bowel Disease a Risk Factor for Severe Acute Respiratory Syndrome Coronavirus 2?

Çavuş B., Akyüz F., Örmeci Çifçibaşı A., Özgür İ., Erel C., Yakut A., et al.

The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology , cilt.33, sa.3, ss.196-204, 2022 (SCI-Expanded) Sürdürülebilir Kalkınma

31. Evaluation of safety and efficacy of tenofovir disoproxil in hemodialysis and renal transplant patients monoinfected with hepatitis B virus based on real life data.

Akyüz F., Çavuş B., Nizam N., Göktürk S., Baran B., Yazıcı H., et al.

Clinical and experimental hepatology , cilt.8, sa.1, ss.7-13, 2022 (Hakemli Dergi) Sürdürülebilir Kalkınma

32. EVALUATION OF HELICOBACTER PYLORI FREQUENCY AND GASTRIC ANTRUM PATHOLOGY FINDINGS IN PATIENTS WITH PORTAL HYPERTENSION

Cavus B., Ormeci A., Evirgen S., Iliaz R., Atasoy A., Yegen G., et al.

JOURNAL OF ISTANBUL FACULTY OF MEDICINE-ISTANBUL TIP FAKULTESI DERGISI , cilt.85, sa.2, ss.211-215, 2022 (ESCI)

33. Is there any predictor for relapse after treatment withdrawal in autoimmune hepatitis patients in the real life?

Cavus B., Akyuz F., Iliaz R., Atasoy A., Akyuz U., Demir K., et al.

INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY , cilt.36, 2022 (SCI-Expanded) Sürdürülebilir Kalkınma

34. Can Interferon Therapy Change the Natural Course of Hepatitis Delta Infection?: a Clinical and Pathological Study

BAKKALOĞLU O. K., Yildirim O., Cavus B., Evirgen S., Gokturk S., Ormeci A., et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY , cilt.66, sa.1, 2022 (SCI-Expanded) Sürdürülebilir Kalkınma

35. A mysterious cause of recurrent acute liver dysfunction for over a decade

Dirim A. B., Kalayci T., Guzel Dirim M., Demir S., Cavus B., Cifcibasi Ormeci A., et al.

GASTROENTEROLOGY REPORT , cilt.10, 2022 (SCI-Expanded)

36. Prevalence and Association of Restless Leg Syndrome, Depression and Anxiety in Patients With Inflammatory Bowel Disease

Iliaz R., Ozturk N. B., Kilicarslan A. F., Akas R., Guzey D. Y., Senel E., et al.

AMERICAN JOURNAL OF GASTROENTEROLOGY , cilt.116, 2021 (SCI-Expanded)

37. Is belching increasing after bariatric bypass surgery in the long term period?

Akyüz F., Göksoy B., Telli P., Nizam N., Atasoy A., Çavus B., et al.

Acta gastro-enterologica Belgica , cilt.84, sa.4, ss.601-605, 2021 (SCI-Expanded)

38. Complementary Roles of Cadaveric and Living Donor Liver Transplantation in Acute Liver Failure.

Özden İ., Yavru H. A., Durmaz Ö., Orhun G., Salmaslıoğlu A., Güllüoğlu M., et al.

Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract , cilt.25, sa.10, ss.2516-2523, 2021 (SCI-Expanded)

39. Etiology of Cirrhosis in Turkey: A National Cohort Study

YILDIRIM A. E., ÜÇBİLEK E., Oruncu M. B., TURAN İ., DEMİR M., Koksal A., et al.

JOURNAL OF HEPATOLOGY , cilt.75, 2021 (SCI-Expanded)

40. The development of extraintestinal manifestation and related risk factors in Crohn's patients

Kayar Y., Dertli R., Konur S., Agin M., Baran B., Ormeci A., et al.

IRISH JOURNAL OF MEDICAL SCIENCE , cilt.190, sa.2, ss.597-604, 2021 (SCI-Expanded)

41. ATA Index: A novel score for predicting fibrosis stage in chronic viral hepatitis.

Tugsal H. Y., Yuksel S., Kabacam G., Evirgen S., Akan K., Akyuz F., et al.

Hepatology forum , cilt.2, sa.1, ss.12-19, 2021 (ESCI)

42. The case for simplifying and using absolute targets for viral hepatitis elimination goals

Razavi H., Blach S., Razavi-Shearer D., Abaalkhail F., Abbas Z., Abdallah A., et al.

Journal of Viral Hepatitis , cilt.28, sa.1, ss.12-19, 2021 (SCI-Expanded)

43. Hepatocellular Carcinoma Metastasis to the Foot

Seyithanoglu D., Cavus B., Cifcibasi Ormeci A., Buyukbabani N., Poyanli A., Kaymakoglu S.

TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGY , cilt.36, sa.2, ss.234-235, 2021 (ESCI)

44. Steroid-induced reconstitution of the biliary tree ravaged by IgG4-related disease

Ozden I., Poyanli A., Sanli Y., Kaymakoglu S.

CLINICAL CASE REPORTS , cilt.8, sa.12, ss.3553-3554, 2020 (ESCI)

45. The COVID-19 pandemic: Clinical practice advice for gastroenterologists, hepatologists, and liver transplant specialists

Kabacam G., Dayangac M., ÜÇBİLEK E., Ercin C. N., Gunsar F., Akyilchz M., et al.

TURKISH JOURNAL OF GASTROENTEROLOGY , cilt.31, sa.5, ss.348-355, 2020 (SCI-Expanded) Sürdürülebilir Kalkınma

46. A micro-elimination approach to addressing hepatitis C in Turkey

İDİLMAN R., Razavi H., Robbins-Scott S., AKARCA U. S., ÖRMECİ N., Kaymakoglu S., et al.

BMC HEALTH SERVICES RESEARCH , cilt.20, sa.1, 2020 (SCI-Expanded)

47. The effect of liver test abnormalities on the prognosis of COVID-19.

Medetalibeyoglu A., Catma Y., Senkal N., Ormeci A., Cavus B., Kose M., et al.

Annals of hepatology , cilt.19, sa.6, ss.614-621, 2020 (SCI-Expanded) Sürdürülebilir Kalkınma

48. Changing epidemiology of chronic hepatitis C: patients are older and at a more advanced stage at the time of diagnosis

Iliaz R., Yuce T., Torun S., Cavus B., Gulluoglu M., Bozaci M., et al.

European journal of gastroenterology & hepatology , cilt.31, sa.10, ss.1247-1249, 2019 (SCI-Expanded) Sürdürülebilir Kalkınma

49. THE ASSESSMENT OF RENAL TRANSPLANT PATIENTS REGARDING MICRO-ELIMINATION OF CHRONIC VIRAL HEPATITISES IN TURKEY: AN ANALYSIS OF 2410 PATIENTS

Turkmen A., Bakir E. A., Bolukbas C., Sinangil A., Kocak E., Uyar M., et al.

TRANSPLANT INTERNATIONAL , cilt.32, ss.194, 2019 (SCI-Expanded)

50. Risk factors associated with progression to intestinal complications of Crohn disease

Kayar Y., Baran B., Ormeci A., Akyuz F., Demir K., Besisik F., et al.

CHINESE MEDICAL JOURNAL , cilt.132, sa.20, ss.2423-2429, 2019 (SCI-Expanded)

51. The Clinical Significance of JAK2V617F Mutation for Philadelphia-Negative Chronic Myeloproliferative Neoplasms in Patients with Splanchic Vein Thrombosis

Hindilerden F., Hindilerden I. Y., Pinarbasi B., HANÇER V. S., Kaymakoglu S., Kucukkaya R. D., et al.

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA , cilt.19, 2019 (SCI-Expanded)

52. Cryptogenic liver cirrhosis and hepatitis E virus (HEV): Are they related?

Akyuz F., Cavus B., Pinarbasi B., Bozaci M., Baran B., Akyuz U., et al.

Annals of Hepatology , cilt.18, sa.4, ss.585-589, 2019 (SCI-Expanded) Sürdürülebilir Kalkınma

53. Inflammatory bowel disease and mycobacteria: how much can we trust isoniazid prophylaxis during antitumor necrosis factor therapy?

Akyuz F., Cavus B., Iliaz R., Soyer O. M., Ormeci A., Evirgen S., et al.

EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY , cilt.31, sa.7, ss.777-780, 2019 (SCI-Expanded) Sürdürülebilir Kalkınma

54. Low recurrence rate of hepatocellular carcinoma following ledipasvir and sofosbuvir treatment in a real-world chronic hepatitis C patients cohort

İDİLMAN R., DEMİR M., ALADAĞ M., Erol C., Cavus B., Iliaz R., et al.

JOURNAL OF VIRAL HEPATITIS , cilt.26, sa.6, ss.666-674, 2019 (SCI-Expanded) Sürdürülebilir Kalkınma

55. Evaluation of drug resistance mutations in patients with chronic hepatitis B

Alaçam S., Karabulut N., Yolcu A., Onel M., Atasoy A., Kaymakoglu S., et al.

FOLIA MICROBIOLOGICA , cilt.64, sa.2, ss.237-243, 2019 (SCI-Expanded) Sürdürülebilir Kalkınma

56. Does the number of mucosal immune cells differ in irritable bowel syndrome and its subtypes?

İLIAZ R., AKYÜZ F., Yeğen G., ÖRMECI A., GÖKTÜRK S., AKYÜZ Ü., et al.

TURKISH JOURNAL OF GASTROENTEROLOGY , cilt.29, sa.4, ss.384-391, 2018 (SCI-Expanded)

57. Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study

Razavi-Shearer D., Gamkrelidze I., Nguyen M. H., Chen D., Van Damme P., Abbas Z., et al.

LANCET GASTROENTEROLOGY & HEPATOLOGY , cilt.3, sa.6, ss.383-403, 2018 (SCI-Expanded) Sürdürülebilir Kalkınma

58. Immunosuppressive therapy and the risk of hepatitis B reactivation: Consensus report

AYGEN B., DEMİR A. M., GÜMÜŞ M., Karabay O., Kaymakoglu S., KÖKSAL A. Ş., et al.

TURKISH JOURNAL OF GASTROENTEROLOGY , cilt.29, sa.3, ss.259-269, 2018 (SCI-Expanded) Sürdürülebilir Kalkınma

59. Mutations in Core Gene Region of Hepatitis B Virus in Patients with Chronic Hepatitis B.

Ciftci S., Keskin F., Abaci N., Akyuz F., Cakiris A., Badur S., et al.

Clinical laboratory , cilt.64, ss.303-310, 2018 (SCI-Expanded) Sürdürülebilir Kalkınma

60. Predicting mortality in patients with spontaneous bacterial peritonitis using routine inflammatory and biochemical markers

Iliaz R., Ozpolat T., Baran B., Demir K., Kaymakoglu S., Besisik F., et al.

European Journal of Gastroenterology and Hepatology , cilt.30, sa.7, ss.786-791, 2018 (SCI-Expanded) Sürdürülebilir Kalkınma

61. Current state and clinical outcome in Turkish patients with hepatocellular carcinoma

Ekinci O., Baran B., Ormeci A., Soyer O. M., Gokturk S., Evirgen S., et al.

WORLD JOURNAL OF HEPATOLOGY , cilt.10, sa.1, ss.51-61, 2018 (ESCI)

62. Serum Glypican-3, Vascular Endothelial Growth Factor, and lnterleukin-6 Levels in Hepatocellular Carcinoma

Serilmez M., Akyuz F., Ormeci Ciftcibasi A., Karabulut S., Kaymakoglu S., Yasasever V., et al.

TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGY , cilt.33, sa.1, ss.18-27, 2018 (ESCI)

63. Recommendation for treatment of hepatitis C virus infection

KAYMAKOĞLU S., Koksal I., KAYMAKOĞLU S., Tabak F., Akarca U. S., Akbulut A., et al.

TURKISH JOURNAL OF GASTROENTEROLOGY , cilt.28, 2017 (SCI-Expanded) Sürdürülebilir Kalkınma

64. Diagnosis, management and treatment of hepatitis delta virus infection: Turkey 2017 Clinical Practice Guidelines

Yurdaydin C., Tabak F., KAYMAKOĞLU S., Tabak F., AKARSU M., Akinci E. G., et al.

TURKISH JOURNAL OF GASTROENTEROLOGY , cilt.28, 2017 (SCI-Expanded) Sürdürülebilir Kalkınma

65. Diagnosis, management and treatment of hepatitis B virus infection: Turkey 2017 Clinical Practice Guidelines

Tabak F., Yurdaydin C., KAYMAKOĞLU S., Tabak F., AKARSU M., Akinci E. G., et al.

TURKISH JOURNAL OF GASTROENTEROLOGY , cilt.28, 2017 (SCI-Expanded) Sürdürülebilir Kalkınma

66. Turkey 2017 Clinical Practice Guidelines on recommendations for screning diagnosing and managing hepatitis C virus

Idilman R., Baykam N., KAYMAKOĞLU S., Tabak F., Bahcecioglu H. I., Bektas A., et al.

TURKISH JOURNAL OF GASTROENTEROLOGY , cilt.28, 2017 (SCI-Expanded) Sürdürülebilir Kalkınma

67. Global prevalence and genotype distribution of hepatitis C virus infection in 2015: A modelling study

Blach S., Zeuzem S., Manns M., Altraif I., Duberg A., Muljono D. H., et al.

The Lancet Gastroenterology and Hepatology , cilt.2, sa.3, ss.161-176, 2017 (Scopus)

68. Belching in irritable bowel syndrome: An impedance study

Obekli T., Akyuz F., Akyuz U., Arici S., Iliaz R., Gokturk S., et al.

Journal of Neurogastroenterology and Motility , cilt.23, sa.3, ss.409-414, 2017 (SCI-Expanded)

69. Role of biochemistry and cytological analysis of cyst fluid for the differential diagnosis of pancreatic cysts A retrospective cohort study

Soyer O. M., Baran B., Ormeci A., Sahin D., Gokturk S., Evirgen S., et al.

MEDICINE , cilt.96, sa.1, 2017 (SCI-Expanded)

70. Analysis of hepatitis C virus NS5A region in patients with cirrhosis using an ultra-deep pyrosequencing method

Keskin F., Ciftci S., Akyuz F., Abaci N., Cakiris A., Akyuz U., et al.

Clinical Laboratory , cilt.63, sa.9, ss.1439-1445, 2017 (SCI-Expanded) Sürdürülebilir Kalkınma

71. Role of several cytokines and adhesion molecules in the diagnosis and prediction of survival of hepatocellular carcinoma

Iliaz R., Akyuz U., Tekin D., Serilmez M., Evirgen S., Cavus B., et al.

Arab Journal of Gastroenterology , cilt.17, sa.4, ss.164-167, 2016 (SCI-Expanded, Scopus)

72. Predictors of treatment requirement in HBeAg-negative chronic hepatitis B patients with persistently normal alanine aminotransferase and high serum HBV DNA levels

Ormeci A., Aydın Y., Sumnu A., Baran B., Soyer O. M., Pinarbasi B., et al.

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES , cilt.52, ss.68-73, 2016 (SCI-Expanded) Sürdürülebilir Kalkınma

73. Retention during capsule endoscopy: Is it a real problem in routine practice?

Ormeci A., Akyuz F., Baran B., Gokturk S., Ormeci T., Pinarbasi B., et al.

JOURNAL OF INTERNATIONAL MEDICAL RESEARCH , cilt.44, sa.4, ss.968-975, 2016 (SCI-Expanded)

74. Does gastroesophageal reflux increase chronic obstructive pulmonary disease exacerbations?

Iliaz S., Iliaz R., Onur S. T., Arici S., Akyuz U., Karaca C., et al.

Respiratory Medicine , cilt.115, ss.20-25, 2016 (SCI-Expanded)

75. Can Helicobacter pylori be eradicated with high-dose proton pump inhibitor in extensive metabolizers with the CYP2C19 genotypic polymorphism?

ORMECI A., Emrence Z., BARAN B., SOYER O., GOKTURK S., EVIRGEN S., et al.

EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES , cilt.20, sa.9, ss.1795-1797, 2016 (SCI-Expanded)

76. Comparison of the efficacy of 12 months and longer courses of interferon therapy for the treatment of chronic delta hepatitis: a retrospective cohort study

Soyer O. M., Baran B., Ormeci A., Gokturk S., Aydin E., Onel D., et al.

POSTGRADUATE MEDICINE , cilt.128, sa.4, ss.432-438, 2016 (SCI-Expanded) Sürdürülebilir Kalkınma

77. What is the impact of capsule endoscopy in the long term period?

Ormeci A., Akyuz F., Baran B., Gokturk S., Ormeci T., Pinarbasi B., et al.

WORLD JOURNAL OF GASTROINTESTINAL ENDOSCOPY , cilt.8, sa.7, ss.344-348, 2016 (ESCI)

78. Viral hepatitis screening guideline before biological drug use in rheumatic patients

KARADAĞ Ö., Kasifoglu T., Ozer B., Kaymakoglu S., KUS Y., Inanc M., et al.

EUROPEAN JOURNAL OF RHEUMATOLOGY , cilt.3, sa.1, ss.25-28, 2016 (ESCI) Sürdürülebilir Kalkınma

79. Effect of cytochrome P450 2C19 polymorphisms on the Helicobacter pylori eradication rate following two-week triple therapy with pantoprazole or rabeprazole

Ormeci A., Emrence Z., Baran B., Gokturk S., Soyer O. M., Evirgen S., et al.

EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES , cilt.20, sa.5, ss.879-885, 2016 (SCI-Expanded)

80. Steroid-refractory inflammatory bowel disease is a risk factor for CMV infection

Ormeci A., Akyuz F., BARAN B., SOYER O., GÖKTÜRK S., ONEL M., et al.

European Review for Medical and Pharmacological Sciences , cilt.20, sa.5, ss.858-865, 2016 (SCI-Expanded)

81. Seroprevalence of hepatitis B and C virus infections and risk factors in Turkey: a fieldwork TURHEP study

Tozun N., Ozdogan O., Cakaloglu Y., Idilman R., Karasu Z., Akarca U., et al.

CLINICAL MICROBIOLOGY AND INFECTION , cilt.21, sa.11, ss.1020-1026, 2015 (SCI-Expanded) Sürdürülebilir Kalkınma

82. Tenofovir disoproxil fumarate has a substantial efficacy against multidrug-resistant strains of hepatitis B virus

Baran B., Soyer O. M., Ormeci A., Gokturk S., Evirgen S., Akyuz F., et al.

LIVER INTERNATIONAL , cilt.35, sa.10, ss.2265-2274, 2015 (SCI-Expanded) Sürdürülebilir Kalkınma

83. ROLE OF THE TACROLIMUS IN POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME

Orhan E. K., Alpsan H., Bebek N., Pinarbasi B., Kaymakoglu S., Ozden I., et al.

NOBEL MEDICUS , cilt.11, sa.3, ss.80-83, 2015 (ESCI)

84. Role of the tacrolimus in posterior reversible encephalopathy syndrome Posterior Geri Dönüşümlü Ensefalopati Sendromunda Tacrolimus’un Rolü

Orhan E., ALPSAN H., BEBEK N., PINARBAŞI B., KAYMAKOĞLU S., ÖZDEN İ., et al.

Nobel Medicus , cilt.11, sa.3, ss.80-83, 2015 (Scopus)

85. In Situ Adenocarcinoma of the Ileum in Crohn’s Disease: A Possible Link with Latent CMV Infection?

KAYMAKOĞLU S., Baran B., Goksel S., Ince U., BAKIR B., Bugra D., et al.

Journal of Gastrointestinal Cancer , cilt.45, sa.1, ss.252-256, 2014 (Scopus)

86. Treatment of Hepatocellular Cancer Due to Hepatitis Delta with Yttrium-90 Radioembolization in a Patient with Cirrhosis: A Case Report

UYANIKOĞLU A., AKYÜZ F., Ermis F., KAYMAKOĞLU S.

VIRAL HEPATIT DERGISI-VIRAL HEPATITIS JOURNAL , cilt.20, sa.3, ss.131-133, 2014 (ESCI) Sürdürülebilir Kalkınma

87. Small bowel mucosal damage in familial Mediterranean fever: results of capsule endoscopy screening

Demir A., Akyuz F., Gokturk S., Evirgen S., Akyuz U., Ormeci A., et al.

SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY , cilt.49, sa.12, ss.1414-1418, 2014 (SCI-Expanded)

88. Effects of Polymorphisms in Interferon lambda 3 (Interleukin 28B) on Sustained Virologic Response to Therapy in Patients With Chronic Hepatitis D Virus Infection

Yilmaz E., Baran B., Soyer O. M., Onel M., Onel D., Ormeci A., et al.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY , cilt.12, sa.10, ss.1753-1758, 2014 (SCI-Expanded) Sürdürülebilir Kalkınma

89. Infliximab in inflammatory bowel disease: attention to adverse events

Uyanikoglu A., Ermis F., Akyuz F., Pinarbasi B., Baran B., Aydogan T., et al.

EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES , cilt.18, sa.16, ss.2337-2342, 2014 (SCI-Expanded)

90. Acute hepatitis B due to immune-escape mutations in a naturally immune patient

Kaymakoglu S., Baran B., Onel D., Badur S., Atamer T., Akyuz F.

ACTA GASTRO-ENTEROLOGICA BELGICA , sa.2, ss.262-265, 2014 (SCI-Expanded) Sürdürülebilir Kalkınma

91. Historical epidemiology of hepatitis C virus (HCV) in selected countries

Bruggmann P., Berg T., Ovrehus A. L. H., Moreno C., Brandao Mello C. E., Roudot-Thoraval F., et al.

JOURNAL OF VIRAL HEPATITIS , cilt.21, ss.5-33, 2014 (SCI-Expanded) Sürdürülebilir Kalkınma

92. The present and future disease burden of hepatitis C virus (HCV) infection with today's treatment paradigm

Razavi H., Waked I., Sarrazin C., Myers R. P., Idilman R., Calinas F., et al.

JOURNAL OF VIRAL HEPATITIS , cilt.21, ss.34-59, 2014 (SCI-Expanded) Sürdürülebilir Kalkınma

93. Strategies to manage hepatitis C virus (HCV) disease burden

Wedemeyer H., Duberg A. S., Buti M., Rosenberg W. M., Frankova S., Esmat G., et al.

JOURNAL OF VIRAL HEPATITIS , cilt.21, ss.60-89, 2014 (SCI-Expanded) Sürdürülebilir Kalkınma

94. Analysis of potential antiviral resistance mutation profiles within the HBV reverse transcriptase in untreated chronic hepatitis B patients using an ultra-deep pyrosequencing method

Ciftci S., Keskin F., Cakiris A., Akyuz F., Pinarbasi B., Abaci N., et al.

DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE , cilt.79, sa.1, ss.25-30, 2014 (SCI-Expanded) Sürdürülebilir Kalkınma

95. Treatment failure may lead to accelerated fibrosis progression in patients with chronic hepatitis C

Baran B., Gulluoglu M., Soyer O. M., Ormeci A., Gokturk S., Evirgen S., et al.

JOURNAL OF VIRAL HEPATITIS , cilt.21, sa.2, ss.111-120, 2014 (SCI-Expanded) Sürdürülebilir Kalkınma

96. Efficacy of tenofovir in adefovir-experienced patients compared with treatment-naive patients with chronic hepatitis B

KESKİN O., Ormeci A., Baran B., Kabacam G., Tuzun A., Karatayli E., et al.

ANTIVIRAL THERAPY , cilt.19, sa.6, ss.543-550, 2014 (SCI-Expanded) Sürdürülebilir Kalkınma

97. Role of the line probe assay INNO-LiPA HBV DR and ultradeep pyrosequencing in detecting resistance mutations to nucleoside/nucleotide analogues in viral samples isolated from chronic hepatitis B patients

Mese S., Arikan M., Cakiris A., Abaci N., Gumus E., Kursun O., et al.

JOURNAL OF GENERAL VIROLOGY , cilt.94, ss.2729-2738, 2013 (SCI-Expanded) Sürdürülebilir Kalkınma

98. Co-infection with hepatitis B does not alter treatment response in chronic hepatitis C

Uyanikoglu A., Akyuz F., Baran B., Simsek B. P., Ermis F., Demir K., et al.

CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY , cilt.37, sa.5, ss.485-490, 2013 (SCI-Expanded) Sürdürülebilir Kalkınma

99. A multicenter, randomized, prospective study of 14-day ranitidine bismuth citrate- vs. lansoprazole-based triple therapy for the eradication of Helicobacter pylori in dyspeptic patients

Avsar E., TIFTIKCI A., Poturoglu S., Erzin Y., KOCAKAYA O., DİNÇER D., et al.

TURKISH JOURNAL OF GASTROENTEROLOGY , cilt.24, sa.4, ss.316-321, 2013 (SCI-Expanded)

100. Durability of sustained virologic response in chronic hepatitis C

UYANIKOĞLU A., Kaymakoglu S., Danalioglu A., Akyuz F., Ermis F., Pinarbasi B., et al.

Gut and Liver , cilt.7, sa.4, ss.458-461, 2013 (SCI-Expanded) Sürdürülebilir Kalkınma

101. Rosai-Dorfman disease with diffuse gastrointestinal involvement

Baran B., Karaca C., Soyer O. M., Yonal I., Isiklar A. D., Cakmak R., et al.

EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY , cilt.25, sa.7, ss.869-874, 2013 (SCI-Expanded)

102. Effect of Genotypic Differences in CYP2C19 and on Cure Rates for Helicobacter pylori Infection by Triple Therapy With Different Proton Pump Inhibitors

Demir K., ORMECI A., Emrence Z., Gokturk S., Baran B., SOYER O. M., et al.

GASTROENTEROLOGY , cilt.144, sa.5, 2013 (SCI-Expanded)

103. Efficacy of Tenofovir in Patients with Lamivudine Failure Is Not Different from That in Nucleoside/Nucleotide Analogue-Naive Patients with Chronic Hepatitis B

Baran B., Soyer O. M., Ormeci A., Gokturk S., Evirgen S., Bozbey H. U., et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY , cilt.57, sa.4, ss.1790-1796, 2013 (SCI-Expanded) Sürdürülebilir Kalkınma

104. Association of the MEFV Gene Variations With Inflammatory Bowel Disease in Turkey

Akyuz F., Besisik F., Ustek D., Ekmekci C., Uyar A., Pinarbasi B., et al.

JOURNAL OF CLINICAL GASTROENTEROLOGY , cilt.47, sa.3, 2013 (SCI-Expanded)

105. Efficacy of pegylated interferon-alpha treatment for 24 months in chronic delta hepatitis and predictors of response

Karaca C., Soyer O. M., Baran B., Ormeci A., Gokturk S., Aydin E., et al.

ANTIVIRAL THERAPY , cilt.18, sa.4, ss.561-566, 2013 (SCI-Expanded)

106. Measurement of the coronary flow velocity reserve in patients with non-alcoholic fatty liver disease

Pinarbasi B., Demir K., Oflaz H., Ahishali E., Akyuz F., Elitok A., et al.

TURKISH JOURNAL OF GASTROENTEROLOGY , cilt.23, sa.6, ss.720-726, 2012 (SCI-Expanded)

107. The clinical significance of JAK2V617F mutation for Philadelphia-negative chronic myeloproliferative neoplasms in patients with splanchnic vein thrombosis

Yonal I., Pinarbasi B., Hindilerden F., Hancer V. S., Nalcaci M., Kaymakoglu S., et al.

JOURNAL OF THROMBOSIS AND THROMBOLYSIS , cilt.34, sa.3, ss.388-396, 2012 (SCI-Expanded)

108. Etiological factors of duodenal and gastric ulcers

Uyanikoglu A., Danalioglu A., Akyuz F., Ermis F., Gulluoglu M., Kapran Y., et al.

Turkish Journal of Gastroenterology , cilt.23, sa.2, ss.99-103, 2012 (SCI-Expanded)

109. Current hepatitis delta virus type 1 (HDV1) infections in central and eastern Turkey indicate a wide genetic diversity that is probably linked to different HDV1 origins

Le Gal F., Badur S., Al Hawajri N., Akyuz F., Kaymakoglu S., Brichler S., et al.

ARCHIVES OF VIROLOGY , cilt.157, sa.4, ss.647-659, 2012 (SCI-Expanded) Sürdürülebilir Kalkınma

110. Should maintenance therapy be performed in ulcerative proctitis? How long should it be continued?

Yonal O., Hatemi G., Kaymakoglu S.

TURKISH JOURNAL OF GASTROENTEROLOGY , cilt.23, ss.21-24, 2012 (SCI-Expanded)

111. Second-Line Levofloxacin-Based Triple Therapy's Efficiency for Helicobacter pylori Eradication in Patients With Peptic Ulcer

Ermis F., Akyuz F., Uyanikoglu A., Kurt R., Pinarbasi B., Nazik H., et al.

SOUTHERN MEDICAL JOURNAL , cilt.104, sa.8, ss.579-583, 2011 (SCI-Expanded)

112. Postprandial platelet-poor plasma 5-hydroxytryptamine concentrations during diarrhea and constipation periods of alternatingtype irritable bowel syndrome patients

Sen F., Pinarbasi B., Issever H., Akyuz F., Mungan Z., Kaymakoglu S.

TURKISH JOURNAL OF GASTROENTEROLOGY , cilt.22, sa.3, ss.270-278, 2011 (SCI-Expanded) Sürdürülebilir Kalkınma

113. Anticoagulant therapy and Budd-Chiari syndrome: Is it successful?

Akyuz F., Cakaloglu Y., Pinarbasi B., Demir K., Akyuz U., Ozdil S., et al.

Hepato-Gastroenterology , cilt.58, ss.900-903, 2011 (SCI-Expanded)

114. Effect of proton pump inhibitor (PPI) treatment in obstructive sleep apnea syndrome: An esophageal impedance-pHmetry study

Ermis F., Akyuz F., Arici S., Uyanikoglu A., Yakar F., Pinarbasi B., et al.

Hepato-Gastroenterology , cilt.58, ss.1566-1573, 2011 (SCI-Expanded)

115. A rare complication of interferon treatment: optic neuropathy

Gokturk S., Atay K., ÇİFCİBAŞI ÖRMECİ A., Baran B., Soyer O. M., AKYÜZ F., et al.

ANNALS OF GASTROENTEROLOGY , cilt.24, sa.4, ss.335, 2011 (ESCI)

116. Is portal hypertensive enteropathy an important additional cause of blood loss in portal hypertensive patients?

Akyuz F., Pinarbasi B., Ermis F., Uyanikoglu A., Demir K., Ozdil S., et al.

Scandinavian Journal of Gastroenterology , cilt.45, sa.12, ss.1497-1502, 2010 (SCI-Expanded)

117. Decreased prohepcidin levels in patients with HBV-related liver disease: relation with ferritin levels.

Yonal O., Akyuz F., Demir K., Ciftci S., Keskin F., Pinarbasi B., et al.

Digestive diseases and sciences , cilt.55, sa.12, ss.3548-51, 2010 (SCI-Expanded) Sürdürülebilir Kalkınma

118. How should we follow the Crohn's disease patients in remission?

Yonal O., Kaymakoglu S.

TURKISH JOURNAL OF GASTROENTEROLOGY , cilt.21, sa.1, ss.97-99, 2010 (SCI-Expanded)

119. Electron microscopic findings in non-alcoholic fatty liver disease: Is there a difference between hepatosteatosis and steatohepatitis?

Ahishali E., Demir K., Ahishali B., Akyuz F., Pinarbasi B., Poturoglu S., et al.

Journal of Gastroenterology and Hepatology (Australia) , cilt.25, sa.3, ss.619-626, 2010 (SCI-Expanded)

120. The quality of life in hemodialysis patients with chronic hepatitis C virus infection

Akyuz F., Besisik F., Pinarbasi B., Demir K., Kaymakoglu S., Cakaloglu Y., et al.

Turkish Journal of Gastroenterology , cilt.20, sa.4, ss.243-246, 2009 (SCI-Expanded) Sürdürülebilir Kalkınma

121. A short course of add-on adefovir dipivoxil treatment in lamivudine-resistant chronic hepatitis B patients

Idilman R., Kaymakoglu S., Onder F. O., Ahishali E., Bektas M., Cinar K., et al.

JOURNAL OF VIRAL HEPATITIS , cilt.16, sa.4, ss.279-285, 2009 (SCI-Expanded) Sürdürülebilir Kalkınma

122. Are acquired hepatocerebral degeneration and hepatic myelopathy reversible?

Pinarbasi B., Kalymakoglu S., Matur Z., Akyuz F., Demir K., Besisik F., et al.

Journal of clinical gastroenterology , cilt.43, sa.2, ss.176-81, 2009 (SCI-Expanded)

123. Prevalence and virological features of occult hepatitis B virus infection in female sex workers who work uncontrolled in Turkey.

Pinarbasi B., Onel D., Cosan F., Akyuz F., Dirlik N., Cakaloglu Y., et al.

Liver international : official journal of the International Association for the Study of the Liver , cilt.29, sa.2, ss.227-30, 2009 (SCI-Expanded) Sürdürülebilir Kalkınma

124. Relapse of hepatitis B in HBeAg-negative chronic hepatitis B patients who discontinued successful entecavir treatment: The case for continuous antiviral therapy

Shouval D., Lai C., Chang T., Cheinquer H., Martin P., Carosi G., et al.

JOURNAL OF HEPATOLOGY , cilt.50, sa.2, ss.289-295, 2009 (SCI-Expanded) Sürdürülebilir Kalkınma

125. Sustained Response of Hepatitis B e Antigen-Negative Patients 3 Years After Treatment with Peginterferon Alfa-2a

Marcellin P., Bonino F., Lau G. K., Farci P., Yurdaydin C., Piratvisuth T., et al.

Gastroenterology , cilt.136, sa.7, 2009 (SCI-Expanded)

126. A new agent for tumour necrosis factor-alpha inhibition: In vitro effects of dipyridamole in Crohn's disease

Poturoglu S., Kaymakoglu S., Polat N. G., Ibrisim D., Ahishali E., Akyuz F., et al.

SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION , cilt.69, sa.6, ss.696-702, 2009 (SCI-Expanded)

127. MASSIVE BLEEDING DUE TO PARACENTESIS-ACASE REPORT

Kocabay G., Tiryaki B., Sumnu A., Gul E., KAYMAKOĞLU S.

JOURNAL OF ISTANBUL FACULTY OF MEDICINE-ISTANBUL TIP FAKULTESI DERGISI , cilt.72, sa.2, ss.55-57, 2009 (ESCI)

128. Intestinal metaplasia in portal hypertensive gastropathy: A frequent pathology

Ibrisim D., Cevikbas U., Akyuz F., Poturoglu S., Ahishali E., Gulluoglu M., et al.

European Journal of Gastroenterology and Hepatology , cilt.20, sa.9, ss.874-880, 2008 (SCI-Expanded)

129. Vanishing bile duct and Stevens-Johnson syndrome associated with ciprofloxacin treated with tacrolimus

Okan G., Yaylaci S., Peker O., Kaymakoglu S., Saruc M.

WORLD JOURNAL OF GASTROENTEROLOGY , cilt.14, sa.29, ss.4697-4700, 2008 (SCI-Expanded)

130. Entecavir therapy for lamivudine-refractory chronic hepatitis B: Improved virologie, biochemical, and serology outcomes through 96 weeks

Sherman M., Yurdaydin C., Simsek H., Silva M., Liaw Y., Rustgi V. K., et al.

Hepatology , cilt.48, sa.1, ss.99-108, 2008 (SCI-Expanded)

131. Prevalence and clinical significance of SEN-H virus in chronic hepatitis B, C and delta infections in Turkey

Cakaloglu Y., Akyuez F., Bozaci M., Ibrisim D., Pinarbasi B., Demir K., et al.

Turkish Journal of Gastroenterology , cilt.19, sa.2, ss.104-108, 2008 (SCI-Expanded) Sürdürülebilir Kalkınma

132. MEFV gene mutations and inflammatory bowel disease: Is there any effect?

AKYÜZ F., Besisik F., Pinarbasi B., DEMİR K., KAYMAKOĞLU S., Ozdil S., et al.

GASTROENTEROLOGY , cilt.134, sa.4, 2008 (SCI-Expanded)

133. Peptic ulcer disease: What did change in Turkey?

Yazici A., AKYÜZ F., İŞSEVER H., Pinarbasi B., DEMİR K., Ozdil S., et al.

GASTROENTEROLOGY , cilt.134, sa.4, 2008 (SCI-Expanded)

134. A rare cause of hemosuccus pancreaticus: Primary splenic artery aneurysm ruptured into pancreatic serous cystadenoma

Pinarbasi B., Poturoglu S., Yanar H., Gueven K., Akyuez F., Dizdaroglu F., et al.

TURKISH JOURNAL OF GASTROENTEROLOGY , cilt.19, sa.1, ss.57-63, 2008 (SCI-Expanded)

135. Somatostatin and propranolol to treat small-for-size syndrome that occurred despite splenic artery ligation

Oezden I., Kara M., Pinarbasi B., Salmaslioglu A., Yavru A., Kaymakoglu S., et al.

EXPERIMENTAL AND CLINICAL TRANSPLANTATION , cilt.5, sa.2, ss.686-689, 2007 (SCI-Expanded) Sürdürülebilir Kalkınma

136. HFE gene mutation, chronic liver disease, and iron overload in Turkey

YOENAL O., Hatirnaz O., AKYUEZ F., Oezbek U., Demir K., Kaymakoglu S., et al.

DIGESTIVE DISEASES AND SCIENCES , cilt.52, sa.11, ss.3298-3302, 2007 (SCI-Expanded)

137. A case of Aeromonas hydrophila enteritis in the course of ulcerative colitis

Ahishali E., Pinarbasi B., Akyuz F., Ibrisim D., Kaymakoglu S., Mungan Z.

EUROPEAN JOURNAL OF INTERNAL MEDICINE , cilt.18, sa.5, ss.430-431, 2007 (SCI-Expanded) Sürdürülebilir Kalkınma

138. The effects of rosiglitazone, metformin, and diet with exercise in nonalcoholic fatty liver disease

Akyuez F., Demir K., Oezdil S., Aksoy N., Poturoglu S., Ibrisim D., et al.

Digestive Diseases and Sciences , cilt.52, sa.9, ss.2359-2367, 2007 (SCI-Expanded)

139. Pegylatedd interferon alfa-2b monotherapy and pegylated interferon alfa-2b plus lamivudine combination therapy for patients with hepatitis B virus E antigen-negative chronic hepatitis B

Kaymakoglu S., Oguz D., Gur G., Gurel S., Tankurt E., Ersoz G., et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY , cilt.51, sa.8, ss.3020-3022, 2007 (SCI-Expanded) Sürdürülebilir Kalkınma

140. Eosinophilic esophagitis: Case report

Mungan Z., Pinarbasi B., Kaymakoglu S.

TURKISH JOURNAL OF GASTROENTEROLOGY , cilt.18, sa.2, ss.100-102, 2007 (SCI-Expanded)

141. Ülseratif Kolitte Cerrahi Tedavinin Hastaların Yaşam Kalitesi Üzerindeki Etkilerinin Değerlendirilmesi

AKYÜZ N., BALIK E., KANAN N., YAMANER S., KAYMAKOĞLU S., AKYÜZ A., et al.

Kolon ve Rektum Hast Derg , sa.17, ss.88-101, 2007 (Hakemli Dergi)

142. Kronik Hepatit C’li hastalarda, Genotip 1b dışındaki genotiplerle infeksiyonun, lineprrobe assay 5’ UTR ve NS5B bölgesinin Dizilenmesi Yöntemleri ile Araştırılması.

KESKİN F., KAYMAKOĞLU S., Türkoğlu S.

Moleküler tanı dergisi , cilt.3, sa.2, ss.40-44, 2007 (Hakemli Dergi) Sürdürülebilir Kalkınma

143. What is the reason of elevated alanine aminotransferase level in HBeAg negative patients with low viremia: NAFLD or chronic hepatitis?

Demir K., Akyuz F., Ozdil S., Aksoy N., Kaymakoglu S., Poturoglu S., et al.

Annals of Hepatology , cilt.6, sa.2, ss.92-96, 2007 (Scopus) Sürdürülebilir Kalkınma

144. Long-term results of interferon alpha monotherapy in patients with HBeAg-negative chronic hepatitis B

Kaymakoglu S., Danalioglu A., Demir K., Karaca C., Akyuz F., Onel D., et al.

Digestive Diseases and Sciences , cilt.52, sa.3, ss.727-731, 2007 (SCI-Expanded) Sürdürülebilir Kalkınma

145. Lamivudine monotherapy and lamivudine plus interferon alpha combination therapy in HBeAg negative chronic hepatitis B not responding to previous interferon alpha monotherapy

Akyuz F., Kaymakoglu S., Demir K., Aksoy N., Karaca C., Danalioglu A., et al.

Acta Gastro-Enterologica Belgica , cilt.70, sa.1, ss.20-24, 2007 (SCI-Expanded) Sürdürülebilir Kalkınma

146. PERNICIOUS ANEMIA ASSOCIATED WITH CRYPTOGENIC CIRRHOSIS

Cosan F., Pinarbasi B., Ibrisim D., GÜLLÜOĞLU M., DEMİR K., KAYMAKOĞLU S., et al.

JOURNAL OF ISTANBUL FACULTY OF MEDICINE-ISTANBUL TIP FAKULTESI DERGISI , cilt.70, sa.4, ss.107-110, 2007 (ESCI)

147. Intrahepatic and peripheral T-cell responses in genotype 1b hepatitis C virus-infected patients with persistently normal and elevated aminotransferase levels

Akyuz F., Polat N., Kaymakoglu S., Aksoy N., Demir K., Besisik F., et al.

World Journal of Gastroenterology , cilt.11, sa.45, ss.7188-7191, 2005 (SCI-Expanded) Sürdürülebilir Kalkınma

148. Merkel-cell carcinoma arising after liver transplantation: A case report

Esen B., PINARBASI B., Buyukbabani N., Baykal C., Cizmeci O., Demir K., et al.

TRANSPLANTATION PROCEEDINGS , cilt.37, sa.10, ss.4413-4415, 2005 (SCI-Expanded)

149. Psychiatric morbidity and quality of life in chronic hepatitis patients

Ozkan M., Corapcioglu A., Balcioglu I., Ertekin E., Koroglu G., Ozdemir S., et al.

JOURNAL OF PSYCHOSOMATIC RESEARCH , cilt.59, sa.1, ss.42, 2005 (SCI-Expanded) Sürdürülebilir Kalkınma

150. Is there any medical therapeutic option in hepatopulmonary syndrome? A case report

AKYÜZ F., KAYMAKOĞLU S., DEMİR K., Aksoy N., Adalet I., Ökten A.

European Journal of Internal Medicine , cilt.16, sa.2, ss.126-128, 2005 (Scopus)

151. Crohn disease activity evaluated by Doppler ultrasonography of the superior mesenteric artery and the affected small-bowel segments

YEKELER E., DANALIOGLU A., MOVASSEGHI B., YILMAZ S., KARACA C., KAYMAKOGLU S., et al.

JOURNAL OF ULTRASOUND IN MEDICINE , cilt.24, sa.1, ss.59-65, 2005 (SCI-Expanded)

152. Interferon-alpha(2b) induction treatment with or without ribavirin in chronic hepatitis C - A multicenter, randomized, controlled trial

Senturk H., Ersoz G., Ozaras R., Kaymakoglu S., Bozkaya H., Akdogan M., et al.

DIGESTIVE DISEASES AND SCIENCES , cilt.48, sa.6, ss.1124-1129, 2003 (SCI-Expanded) Sürdürülebilir Kalkınma

153. Coexistence of homozygous factor V Leiden mutation and antiphospholipid antibodies in two patients presented with Budd-Chiari syndrome

Diz-Kucukkaya R., Demir K., Yenerel M. N., Nalcaci M., Kaymakoglu S., Inanc M.

HAEMATOLOGIA , cilt.32, sa.1, ss.73-77, 2002 (SCI-Expanded)

154. Assay of Mycobacterium tuberculosis in biopsy specimens taken from hepatic granuloma patients using polymerase chain reaction method

Tuncer İ., KÖKSALAN O. K., DEMİR K., Dinçer D., TÜRKOĞLU S., KAYMAKOĞLU S., et al.

TURKISH JOURNAL OF GASTROENTEROLOGY , cilt.12, sa.3, ss.189-195, 2001 (Scopus) Sürdürülebilir Kalkınma

155. Miconazole induced acute hepatitis and sexual intercourse!

Beşişik F., Dinçer D., DEMİR K., KAYMAKOĞLU S., Çakalǒglu Y., Çevikbaş U., et al.

Turkish Journal of Gastroenterology , cilt.12, sa.1, ss.59-63, 2001 (SCI-Expanded) Sürdürülebilir Kalkınma

156. Sağlık personeli olmak HCV infeksiyonu açısından risk faktörü mü ? Asemptomatik sağlık personelinde HCV seroprevalansı.

Beşışık F., Ökten A., Kaymakoğlu S., BADUR O. S., Yalçın S., AĞAÇFİDAN A.

Gastroenterohepatoloji , cilt.3, sa.3, ss.169-171, 1992 (Hakemli Dergi)

157. Türkiyede sağlıklı bireyler ve akut-NANBH olgularında hepatit E virusu antikorlarının (anti-HEV) araştırılması.

Badur O. S., Dedeoğlu F. B., YENEN O. Ş., Yüksel D., Işık N. H., KAYMAKOĞLU S.

İNFEKSİYON DERGİSİ , cilt.8, sa.1, ss.1-4, 1992 (Hakemli Dergi) Sürdürülebilir Kalkınma

Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 58

1. The Role of MicroRNA-192-5p in the Pathogenesis of Crohn's Disease

Orhan Dicle E., Genç Uluçeçen S., İstemihan Z., Çavuş B., Oğuz F., Kaymakoğlu S., et al.

38th uropean Federation for Immunogenetics Congress, Praha, Çek Cumhuriyeti, 14 - 17 Mayıs 2025, cilt.105, ss.84, (Özet Bildiri)

2. 10-year results under tenofovir disoproxil fumarate and entecavir in chronic hepatitis B; HBV clearance rare, disease outcomes good

İstemihan Z., Kemeç G., Cebeci T., Çetin O., Genç Uluçeçen S., Rüstemzade A., et al.

EASL Congress 2024, Milan, İtalya, 5 - 08 Haziran 2024, ss.803, (Özet Bildiri)

3. The relationship between spleen stiffness and portal hypertension liver transplant patients

Nurıyev K., İstemihan Z., Telli P., Qurbanov A., Yağlı M. A., Dağcı G., et al.

EASL Congress 2024, Milan, İtalya, 5 - 08 Haziran 2024, ss.377-378, (Özet Bildiri)

4. Steatotic liver disease in diabetic patients: more serious diabetes mellitus, more serious liver disease

İstemihan Z., Bektaş F., Bardak A. E., Kızıltaş C., Kemeç G., Nurıyev K., et al.

EASL Congress 2024, Milan, İtalya, 5 - 08 Haziran 2024, ss.551, (Özet Bildiri)

5. Clinical characteristics of patients with hereditary hemorrhagic telangiectasia: Real-life data, single-center experience

İstemihan Z., Bardak A. E., Nurıyev K., Rüstemzade A., Genç Uluçeçen S., Çavuş B., et al.

ESGE Days 2024, Berlin, Almanya, 25 - 27 Nisan 2024, ss.297, (Özet Bildiri)

6. Otoimmün Tanılı Hastalarda Viral Serolojik Profilin Değerlendirilmesi

Küçükkaya S., Çaklovica Küçükkaya İ., Çavuş B., Safran N., Önel M., Kırkoyun Uysal H., et al.

7. Ulusak Klinik Mikrobiyoloji Kongresi (KLİMUD), Muğla, Türkiye, 1 - 05 Kasım 2023, ss.635, (Özet Bildiri)

7. HYPERLIPIDEMIA, ATHEROSCLEROSIS AND HEPATOSTEATOSIS IN PRIMARY BILIARY CHOLANGITIS: WHAT IS THE RISK?

ÇOŞKUN A., Ormeci A. C., ÇAVUŞ B., ŞENKAL İ. V., KARAPINAR E., POYANLI A., et al.

Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD), Massachusetts, Amerika Birleşik Devletleri, 10 - 14 Kasım 2023, (Özet Bildiri)

8. ARE THERE NEW PRACTICAL MARKERS TO PREDICT MALIGNANCY IN PANCREATIC CYST FLUIDS?

Anıl K. U., Çavuş B., Çifcibaşı Örmeci A., İmanov Z., Şenkal İ. V., Nurıyev K., et al.

Digestive Disease Week 2023, Washington, Amerika Birleşik Devletleri, 6 - 09 Mayıs 2023, ss.774, (Özet Bildiri)

9. Tedavi naif ve deneyimli Kronik Hepatit B hastalarında tenofovir alafenamidin gerçek yaşam verileri: daha fazla etki, daha az yan etki

Bektaş E., Yılmaz A., Kıkılı C. İ., Nurıyev K., İstemihan Z., Şenkal İ. V., et al.

39. Ulusal Gastroenteroloji Haftası ve 10. Gastroenteroloji Cerrahisi Kongresi, Antalya, Türkiye, 22 - 27 Kasım 2022, ss.1159-1162, (Özet Bildiri)

10. GRANÜLOMATÖZ HEPATİT VE İNTRAHEPATİK KOLESTAZA BAĞLI HİPERLİPİDEMİ İLE SEYREDEN AKCİĞER-DIŞI SARKOİDOZ OLGUSU

Bektaş E., Yılmaz A., Bilgin E., Mutlu Ü., Çavuş B., Çifcibaşı Örmeci A., et al.

24. Ulusal İç Hastalıkları Kongresi, Antalya, Türkiye, 19 - 23 Ekim 2022, ss.136-137, (Tam Metin Bildiri)

11. REAL-WORLD DATA OF TENOFOVIR ALAFENAMIDE IN TREATMENT-NAIVE AND EXPERIENCED PATIENTS WITH CHRONIC HEPATITIS B: MORE EFFICACY, LESS SIDE EFFECTS

Bektaş E., Yılmaz A., Kıkılı C. İ., Nurıyev K., İstemihan Z., Şenkal İ. V., et al.

AASLD Liver Meeting , District Of Columbia, Amerika Birleşik Devletleri, 4 - 08 Kasım 2022, cilt.76, ss.299, (Özet Bildiri)

12. Dekompanse karaciğer sirozunda ince barsak tutulumlu diffüz büyük b hücreli lenfoma olgusu

Teberik Kama E., İstemihan Z., Çifcibaşı Örmeci A., Akyüz F., Kaymakoğlu S.

24. Ulusal İç Hastalıkları Kongresi, Antalya, Türkiye, 19 - 23 Ekim 2022, ss.140, (Özet Bildiri)

13. İshal ve kilo kaybının nadir bir nedeni:Amiloidoz

Çiftçi A. C., Konyaoğlu H., Şenkal İ. V., Çavuş B., Çifcibaşı Örmeci A., Akyüz F., et al.

21. Çapa Gastroenteroloji Günleri, İstanbul, Türkiye, 31 Mart - 02 Nisan 2022, ss.70, (Tam Metin Bildiri)

14. BILATERAL FEMUR BAŞI AVASKÜLER NEKROZU ILE BAŞVURAN HEMOKROMATOZIS OLGUSU

Yılmaz A., Bektaş E., Gülseren Ü. A., Şenkal İ. V., Nurıyev K., Altınkaynak M., et al.

İstanbul Tıp Fakültesi Geleneksel İç Hastalıkları Günleri İnteraktif Güncelleştirme 2022, Sakarya, Türkiye, 23 - 27 Mart 2022, ss.38-39, (Tam Metin Bildiri)

15. Budd-Chiari Sendromu’nda Hepatoselüler Kanser ve Mortalitenin Değerlendirilmesi

İstemihan Z., Nurıyev K., Şenkal İ. V., İmanov Z., Sarıdal M. K., Akas R., et al.

38. Ulusal Gastroenteroloji Haftası, 9. Gastroenteroloji Cerrahisi Kongresi, Antalya, Türkiye, 16 - 21 Kasım 2021, ss.219, (Özet Bildiri) Sürdürülebilir Kalkınma

16. Ön Segment Optik Koherans Tomografi (OCT), Wilson hastalığı tanısında Kayser Fleischer Halkası varlığını değerlendirmeki yeri - Ehil oftalmolog gerekliliğine son verecek mi?

Çifcibaşı Örmeci A., Bayraktar Ş., Işık A. O., İstemihan Z., Sarıdal M. K., Akas R., et al.

38. Ulusal Gastroenteroloji Haftası, 9. Gastroenteroloji Cerrahisi Kongresi, Antalya, Türkiye, 16 - 21 Kasım 2021, ss.218, (Özet Bildiri)

17. TENOFOVIR DISOPROXIL FUMARATE IN CHRONIC HEPATITIS B: WHAT ARE THE TRIGGERS OF DRUG-RELATED ADVERSE EFFECTS?

Kapar C., Cavus B., Atasoy A., Suleymanova V., Isik A., Karahan L., et al.

Liver Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD), ELECTR NETWORK, 13 - 16 Kasım 2020, cilt.72, (Özet Bildiri) Sürdürülebilir Kalkınma

18. Bariyatrik by-pass cerrahisi sonrası uzun dönemde geğirti artıyor mu?

AKYÜZ F., TELLİ P., nizam n., GÖKSOY B., ATASOY A., ÇAVUŞ B., et al.

7. Gastroenteroloji Cerrahisi Kongresi, Antalya, Türkiye, 29 Kasım - 01 Aralık 2019, ss.99, (Özet Bildiri)

19. Is belching increasing after bariatric by-pass surgery in the long term period?

AKYÜZ F., GÖKSOY B., TELLİ P., NİZAM N., ATASOY A., ÇAVUŞ B., et al.

United European Gastroenterology (UEG) Week 2019, İspanya, 19 - 23 Ekim 2019, cilt.7, ss.703, (Özet Bildiri)

20. Bone health in liver transplant recipients: Corticosteroids preserve their significance, what about late follow-up?

MİRİOĞLU Ş., ÇAKMAK DEMİR S., ILIAZ R., ÇELEN ÖGÜNÇ H., AKYÜZ F., DEMİR K., et al.

AASLD-TASL Connect Regional Meeting, İstanbul, Türkiye, 15 - 16 Mart 2019, cilt.30, ss.21-22, (Tam Metin Bildiri)

21. Bone health in liver transplant recipients: Corticosteroids preserve their significance, what about late follow-up?

MİRİOĞLU Ş., ÇAKMAK DEMİR S., ILIAZ R., ÇELEN ÖĞÜNÇ H., AKYÜZ F., DEMİR K., et al.

AASLD-TASL Connect Regional Meeting, İstanbul, Türkiye, 15 - 16 Mart 2019, cilt.30, ss.21-22, (Özet Bildiri)

22. Clinical Impact of Endosonography in the Differantial Diagnosis of Indeterminate Biliary Strictures

Akyuz F., Deniz R., Karsli S., Akyuz U., Atasoy A., Demir K., et al.

Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD) / Liver Meeting, San-Francisco, Kostarika, 9 - 13 Kasım 2018, cilt.68, (Özet Bildiri)

23. Is It Sufficient Only to Request an Anti-HCV Test for the Performance of HCV Screening?

Deniz R., Karsli S., Ekinci O. B., Kalantarova I., Atasoy A., Onel M., et al.

Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD) / Liver Meeting, San-Francisco, Kostarika, 9 - 13 Kasım 2018, cilt.68, (Özet Bildiri)

24. Böbrek Nakli Alıcılarında Direkt Etkili Antivirallerle HCV Tedavisi

MİRİOĞLU Ş., İSTEMİHAN Z., ŞAHİN E., Aksoy E., DEMİR E., AKGÜL S., et al.

34. Ulusal Nefroloji, Hipertansiyon, Diyaliz ve Transplantasyon Kongresi, Antalya, Türkiye, 18 - 22 Ekim 2017, cilt.26, sa.3, ss.35, (Özet Bildiri)

25. Böbrek Nakli Alıcılarında Direkt Etkili Antivirallerle HCV Tedavisi

MİRİOĞLU Ş., İSTEMİHAN Z., ŞAHİN E., AKSOY E., DEMİR E., USTA AKGÜL S., et al.

34. Ulusal Nefroloji, Hipertansiyon, Diyaliz ve Transplantasyon Kongresi, Antalya, Türkiye, 18 - 22 Ekim 2017, cilt.26, ss.35, (Özet Bildiri)

26. Is there any predictor for relapse after treatment withdrawal in autoimmune hepatitis patients in the real life?

Akyuz F., Iliaz R., Cavus B., Atasoy A., Akyuz U., Demir K., et al.

68th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD) / Liver Meeting, Washington, Kiribati, 20 - 24 Ekim 2017, cilt.66, (Özet Bildiri) Sürdürülebilir Kalkınma

27. Tens asitli siroz hastalarında intraabdominal hipertansiyonun prognoz üzerine etkisi

MUTLU Ü., ATASOY A., ILIAZ R., ÇAVUŞ B., AKYÜZ F., DEMİR K., et al.

11. Ulusal Hepatoloji Kongresi, Antalya, Türkiye, 17 - 21 Mayıs 2017, ss.31-32, (Özet Bildiri)

28. Vitamin D receptor gene polymorphisms may affect the interferon response in chronic hepatitis B patients

AKYÜZ F., UÇAR A. R., ÇİFTÇİ S., KESKİN F., ILIAZ R., ÇAVUŞ B., et al.

26th Annual Conference of APASL, Shanghai, Çin, 15 - 19 Şubat 2017, cilt.11, sa.1, (Tam Metin Bildiri) Sürdürülebilir Kalkınma

29. Kronik hepatit C’li hastalar artık daha yaşlı ve daha ciddi karaciğer hastalığı ile kliniğe başvuruyor

ILIAZ R., YÜCE İNEL T., TORUN E. S., ÇAVUŞ B., GÜLLÜOĞLU M., Bozacı M., et al.

XIII. Ulusal Viral Hepatit Kongresi, Antalya, Türkiye, 17 - 20 Mart 2016, ss.18, (Tam Metin Bildiri) Sürdürülebilir Kalkınma

30. Olgu sunumu: İmmünokompetan hastada dissemine tüberküloz lenfadenopatisi

DİRİM A. B., MİRİOĞLU Ş., ÇAVUŞ B., ILIAZ R., YILMAZBAYHAN E. D., AKYÜZ F., et al.

32. Ulusal Gastroenteroloji Haftası, Antalya, Türkiye, 25 - 29 Kasım 2015, ss.94, (Tam Metin Bildiri) Sürdürülebilir Kalkınma

31. Olgu sunumu: İmmünokompetan hastada dissemine tüberküloz lenfadenopatisi

DİRİM A. B., MİRİOĞLU Ş., ÇAVUŞ B., ILIAZ R., YILMAZBAYHAN E. D., AKYÜZ F., et al.

32. Ulusal Gastroenteroloji Haftası, Antalya, Türkiye, 25 - 29 Kasım 2015, cilt.26, ss.94, (Özet Bildiri)

32. "Normal" Serum ALT/AST Level in Turkish Population

Karasu Z., Tozun N., İDİLMAN R., ÖZDOĞAN O. C., Kaymakoglu S., Cakaloglu Y., et al.

66th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD), San-Francisco, Kostarika, 13 - 17 Kasım 2015, cilt.62

33. Hepatitis C Seropositivity is not as high as Western Countries in the Population Born Between 1945-1965 According to Turkey Nationwide Hepatitis Prevalence Study (TURKHEP 2010)

ÖZDOĞAN O. C., Tozun N., Kaymakoglu S., İDİLMAN R., Karasu Z., AKARCA U. S.

66th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD), San-Francisco, Kostarika, 13 - 17 Kasım 2015, cilt.62 Sürdürülebilir Kalkınma

34. Cyclosporine Therapy As a Rescue Treatment in Acute Severe Ulcerative Colitis: A Real Life-Data From a Tertiary Center

Evirgen S., Iliaz R., AKYÜZ F., ÇAVUŞ B., Pinarbasi B. S., Karaca C., et al.

46th Annual Digestive Disease Week (DDW), Washington, Kiribati, 16 - 19 Mayıs 2015, cilt.148, (Özet Bildiri)

35. Hasta ortada kalmasın Multidisipliner yaklaşım

TÜKEK T., TANAKOL R., KAYMAKOĞLU S., YENEREL M. N., KÖSE M.

"Geleneksel İç Hastalıkları Günleri-İnteraktif Güncelleştirme - 2016", Türkiye, 11 - 13 Mart 2015

36. Chronic Renal Failure after Liver Transplantation in Long Term: Prevalence and Risk Factors.

Gokturk S., Baran B., Ormeci A., Soyer O., Evirgen S., Ozden I., et al.

Joint International Congress of ILTS, ELITA and LICAGE, London, Kanada, 4 - 07 Haziran 2014, cilt.20, (Özet Bildiri)

37. The Course of Pregnancy in Wilson's Disease-One Center, 20 Years' Experience

DEMİR K., Soyer O. M., Karaca C., BEŞIŞIK S. F., KAYMAKOĞLU S., BEŞIŞIK S. F.

55th Annual Meeting of the Society-for-Surgery-of-the-Alimentary-Tract (SSAT) / Digestive Disease Week (DDW), Illinois, Amerika Birleşik Devletleri, 3 - 06 Mayıs 2014, cilt.146, (Özet Bildiri)

38. Risk factors for significant liver fibrosis in genotype D HBeAg-negative chronic hepatitis B infection with persistently normal ALT and high serum HBVDNA levels

Ormeci A., Akyuz F., Baran B., Soyer O. M., Gokturk S., Karaca C., et al.

64th Annual Meeting and Postgraduate Course of the American-Association-for-the-Study-of-Liver-Diseases, Washington, Kiribati, 1 - 05 Kasım 2013, (Özet Bildiri) Sürdürülebilir Kalkınma

39. Safety of Tenofovir in Renal Transplanted and Hemodialysis Patients with Chronic Hepatitis B

Akyuz F., Gokturk S., Baran B., Ormeci A., Soyer O. M., Evirgen S., et al.

64th Annual Meeting and Postgraduate Course of the American-Association-for-the-Study-of-Liver-Diseases, Washington, Kiribati, 1 - 05 Kasım 2013, cilt.58, (Özet Bildiri) Sürdürülebilir Kalkınma

40. Tenofovir disoproxil fumarate has a substantial efficacy against adefovir and multi-drug resistant strains of hepatitis B virus

Baran B., Soyer O. M., Ormeci A., Gokturk S., Evirgen S., Akyuz F., et al.

64th Annual Meeting and Postgraduate Course of the American-Association-for-the-Study-of-Liver-Diseases, Washington, Kiribati, 1 - 05 Kasım 2013, (Özet Bildiri) Sürdürülebilir Kalkınma

41. Virological Supression Does not Prevent the Development of Hepatocellular Carsinoma in Cirrhotic Patients with Genotype D Hepatitis B Infection

Gokturk S., Basar R., Ucar A. R., Basgoze B. H., Altinkaynak M., Buyukballi P., et al.

64th Annual Meeting and Postgraduate Course of the American-Association-for-the-Study-of-Liver-Diseases, Washington, Kiribati, 1 - 05 Kasım 2013, cilt.58, (Özet Bildiri) Sürdürülebilir Kalkınma

42. The antiviral efficacy of entecavir is not influenced by prior treatment with nucleos(t)ide analogues in patients with chronic hepatitis B

Baran B., Soyer O. M., Ormeci A., Gokturk S., Evirgen S., Akyuz F., et al.

64th Annual Meeting and Postgraduate Course of the American-Association-for-the-Study-of-Liver-Diseases, Washington, Kiribati, 1 - 05 Kasım 2013, (Özet Bildiri)

43. Baseline alfa-fetoprotein level is a strong predictor of vascular invasion and survival in patients with hepatocellular carcinoma

Ekinci O., Baran B., Ormeci A., Soyer O. M., Gokturk S., Poyanli A., et al.

64th Annual Meeting and Postgraduate Course of the American-Association-for-the-Study-of-Liver-Diseases, Washington, Kiribati, 1 - 05 Kasım 2013, cilt.58, (Özet Bildiri)

44. Does Chemoprophylaxis Prevent Tuberculosis Reactivation in the Long Term Period of Anti-TNF Treatment?

AKYÜZ F., Soyer O. M., Gokturk S., ÇİFCİBAŞI ÖRMECİ A., Evirgen S., Onder S. Y., et al.

Digestive Disease Week / 28th Annual Residents and Fellows Research Conference of the Society-for-Surgery-of-the-Alimentary-Tract (SSAT), Florida, Amerika Birleşik Devletleri, 18 - 21 Mayıs 2013, cilt.144, (Özet Bildiri)

45. Number connection test-A and inhibitor control test are not efficient for diagnosis of minimal hepatic encephalopathy in cirrhotic patients

Baran B., Ozcan E., Oztop N., Cakmak R., Soyer O. M., Ormeci A., et al.

63rd Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD), Massachusetts, Amerika Birleşik Devletleri, 9 - 13 Kasım 2012, cilt.56, (Özet Bildiri)

46. Response to tenofovir treatment of treatment-naive and adefovir experienced patients with chronic hepatitis b

KESKİN O., Ormeci A., Kabacam G., Akyuz F., Aniktar H., Karaca C., et al.

63rd Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD), Massachusetts, Amerika Birleşik Devletleri, 9 - 13 Kasım 2012, cilt.56, (Özet Bildiri) Sürdürülebilir Kalkınma

47. Investigation of resistance mutations in the HBV DNA samples that isolated from patients with chronic Hepatitis nucleoside/nucleotide analogues by INNO-LIPA HBV DR and ultradeep pyrosequencing methods

MEŞE S., ARIKAN M., ÇAKİRİS A., ABACI N., ÖNEL D., USTEK D., et al.

2nd World Congress on Virology, Las Vegas, Amerika Birleşik Devletleri, 20 - 22 Ağustos 2012, cilt.4, sa.4, ss.147, (Tam Metin Bildiri) Sürdürülebilir Kalkınma

48. Success of Two Different Endoscopic Submucosal Resection Methods in Gastric Subepithelial Lesions

Karaca C., Soyer O. M., Akyuz F., Baran B., Ormeci A., Gokturk S., et al.

Digestive Disease Week (DDW), California, Amerika Birleşik Devletleri, 19 - 22 Mayıs 2012, cilt.75, ss.136, (Özet Bildiri)

49. ANTIVIRAL RESISTANCE IN NAIVE GENOTYPE D CHRONIC HEPATITIS B PATIENTS BY ULTRA-DEEP PYROSEQUENCING

Akyuz F., Ciftci S., Keskin F., Pinarbasi B., Baran B., Ustek D., et al.

62nd Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD), San-Francisco, Kostarika, 4 - 08 Kasım 2011, cilt.54, (Özet Bildiri) Sürdürülebilir Kalkınma

50. A NATIONWIDE PREVALENCE STUDY AND RISK FACTORS FOR HEPATITIS A, B, C AND D INFECTIONS IN TURKEY

Tozun N., ÖZDOĞAN O. C., Cakaloglu Y., İDİLMAN R., Karasu Z., AKARCA U. S., et al.

61st Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases, Massachusetts, Amerika Birleşik Devletleri, 29 Ekim - 02 Kasım 2010, cilt.52, (Özet Bildiri) Sürdürülebilir Kalkınma

51. CLEVUDINE TREATMENT OF CHRONIC DELTA HEPATITIS

Yakut M., Seven G., Baran B., Kabacam G., Karatayli E., BOZDAYI A. M., et al.

52. CLONAL ANALYSIS OF THE QUASISPECIES OF ANTIVIRAL RESISTANT HBV GENOMES IN PATIENTS WITH ENTECAVIR RESISTANCE TREATED WITH RESCUE LAMIVUDINE-ADEFOVIR COMBINATION THERAPY

Karatayli E., İDİLMAN R., Karatayli S. C., Cevik E., AKARCA U. S., Kaymakoglu S., et al.

60th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases, Massachusetts, Amerika Birleşik Devletleri, 30 Ekim - 03 Kasım 2009, cilt.50, (Özet Bildiri)

53. Ultra-Deep Pyrosekans (UDPS) yöntemi ile naiv kronik B hepatitli hastalarda antiviral direnç araştırılması.

AKYÜZ F., ÇİFTÇİ S., KESKİN F., PINARBASI B., ÇAKIRİS A., ABACI N., et al.

26. Ulusal Gastroenteroloji Haftası, Ankara, Türkiye, 14 - 18 Ekim 2008, ss.206, (Özet Bildiri)

54. A new agent for tumour necrosis factor-alpha inhibition: In vitro effects of dipyridamole in Crohn's disease

Poturoglu S., KAYMAKOĞLU S., polat N. G., Ibrisim D., Ahishali E., AKYÜZ F., et al.

Digestive Disease Weeking Meeting/ASGE Postgraduate Course Meeting, Washington, Kiribati, 19 - 24 Mayıs 2007, cilt.132, (Özet Bildiri)

55. Entecavir maintained virologic suppression through 3 years of treatment in antiviral-naive HBeAg(+) patients (ETV 022/901)

Chang T., Chao Y., Kaymakoglu S., Cheinquer H., Pessoa M., Gish R., et al.

57th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases, Massachusetts, Amerika Birleşik Devletleri, 27 - 31 Ekim 2006, cilt.44, (Özet Bildiri)

56. A multicenter, randomized, prospective study of 14 days ranitidine bismuth citrate vs. lansoprazole based triple therapies for the eradication of Helicobacter pylori in dyspeptic patients.

Avsar E., KAYMAKOĞLU S., Erzin Y., Poturoglu S., Dincer D., Tiftikci A., et al.

Annual Meeting of the American-Gastroenterological-Association/Digestive-Disease-Week, Illinois, Amerika Birleşik Devletleri, 14 - 19 Mayıs 2005, cilt.128

57. Combined or monotherapy, which is better in AntiHBe (+) chronic hepatitis B ?

Danalioglu A., KAYMAKOĞLU S., Cakaloglu Y., DEMİR K., AKYÜZ F., Aksoy N., et al.

Digestive Disease Week 2003 Meeting/104th Annual Meeting of the American-Gastroenterological-Association, ORLANDO, FLORIDA, 17 - 22 Mayıs 2003, cilt.124, (Özet Bildiri)

58. Hepatopulmonary Syndrome In Noncirrhotic Portal Hypertensive Patients

Kaymakoğlu S., Kahraman T., Kudat H.

The 34th Annual Meeting Of The European Association For The Study Of The Liver. Naples, Italy. , Naples, İtalya, 8 - 12 Nisan 1999, cilt.30, ss.2-23, (Özet Bildiri)

Metrikler

Yayın

215

Yayın (WoS)

170

Yayın (Scopus)

142

Atıf (WoS)

2043

H-İndeks (WoS)

Atıf (Scopus)

4333

H-İndeks (Scopus)

Atıf (Scholar)

107

H-İndeks (Scholar)

Atıf (TrDizin)

H-İndeks (TrDizin)

Atıf (Diğer Toplam)

Proje

Açık Erişim

BM Sürdürülebilir Kalkınma Amaçları

Yayınlar & Eserler